Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

165.36
-0.3000-0.18%
Post-market: 165.360.00000.00%19:59 EDT
Volume:6.50M
Turnover:1.08B
Market Cap:42.94B
PE:-11.63
High:167.13
Open:166.83
Low:165.11
Close:165.66
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.83
T/O Rate:2.51%
Dividend:2.53
Dividend Rate:1.53%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.25
PE(LYR):-11.63

Loading ...

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Aug 31

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

American Healthcare REIT price target raised to $66 from $61 at Barclays

TIPRANKS
·
Aug 31

Omega Healthcare price target lowered to $50 from $51 at Barclays

TIPRANKS
·
Aug 31

Sabra Health Care price target raised to $23 from $21 at Barclays

TIPRANKS
·
Aug 31

Humana Stock And 2 Healthcare Names Backing The Shift To Preventive Care

Simply Wall St.
·
Aug 31

Promisia clears conditions for Chatswood Retirement Village acquisition

TIPRANKS
·
Aug 31

Regis Healthcare Director Boosts Stake with On-Market Share Purchase

TIPRANKS
·
Aug 31

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Aug 31